BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10409174)

  • 41. Influence of TMB-8 and thapsigargin on vasoconstrictor responses in the pulmonary vascular bed of the cat.
    Ibrahim IN; Hoover JM; Fields AM; Richards TA; Kaye AD
    Am J Ther; 2005; 12(5):411-6. PubMed ID: 16148426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin II-induced vascular dysfunction is mediated by the AT1A receptor in mice.
    Ryan MJ; Didion SP; Mathur S; Faraci FM; Sigmund CD
    Hypertension; 2004 May; 43(5):1074-9. PubMed ID: 15007032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal vascular interaction of angiotensin II and prostaglandins in renovascular hypertension.
    Cruz BV; Escalante B
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):21-7. PubMed ID: 10413062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ropivacaine attenuates pulmonary vasoconstriction induced by thromboxane A2 analogue in the isolated perfused rat lung.
    Fischer LG; Hönemann CW; Patrie JT; Durieux ME; Rich GF
    Reg Anesth Pain Med; 2000; 25(2):187-94. PubMed ID: 10746533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways.
    Henderson KK; Byron KL
    J Appl Physiol (1985); 2007 Apr; 102(4):1402-9. PubMed ID: 17204577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of protein kinase C, tyrosine kinases, and Rho kinase in Ca(2+) handling of human small arteries.
    Martínez MC; Randriamboavonjy V; Ohlmann P; Komas N; Duarte J; Schneider F; Stoclet JC; Andriantsitohaina R
    Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1228-38. PubMed ID: 10993789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats.
    Li XC; Campbell DJ; Ohishi M; Yuan S; Zhuo JL
    Am J Physiol Renal Physiol; 2006 May; 290(5):F1024-33. PubMed ID: 16380463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced constrictor responses of skeletal muscle arterioles during chronic myocardial infarction.
    Didion SP; Carmines PK; Ikenaga H; Mayhan WG
    Am J Physiol; 1997 Sep; 273(3 Pt 2):H1502-8. PubMed ID: 9321843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of reactive oxygen species in Kv channel inhibition and vasoconstriction induced by TP receptor activation in rat pulmonary arteries.
    Cogolludo A; Frazziano G; Cobeño L; Moreno L; Lodi F; Villamor E; Tamargo J; Perez-Vizcaino F
    Ann N Y Acad Sci; 2006 Dec; 1091():41-51. PubMed ID: 17341601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: Role of arterial baroreflexes and vasoreactivity.
    Nasser SA; Sabra R; Elmallah AI; El-Din MM; Khedr MM; El-Mas MM
    Life Sci; 2016 Oct; 163():1-10. PubMed ID: 27575704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of c-Jun N-terminal kinase in the regulation of vascular tone.
    Zhou MS; Schulman IH; Chadipiralla K; Raij L
    J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):78-83. PubMed ID: 20075153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for uneven distribution of L-type calcium channels in rat pulmonary circulation.
    Walker BR
    Am J Physiol; 1995 Dec; 269(6 Pt 2):H2051-6. PubMed ID: 8594916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ciglitazone, a peroxisome proliferator-activated receptor gamma inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure.
    Yousefipour Z; Hercule H; Truong L; Oyekan A; Newaz M
    J Pharmacol Exp Ther; 2007 Aug; 322(2):461-8. PubMed ID: 17494862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
    Erdemli O; Hao Q; Cai B; Lippton HL; Hyman A
    Arch Int Pharmacodyn Ther; 1994; 328(2):165-79. PubMed ID: 7535994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of phospholipase A2, 12-lipoxygenase, and cyclooxygenase inhibitors in the feline pulmonary bed.
    Kaye AD; Nossaman BD; Smith DE; Ibrahim IN; Imig JD; Kadowitz PJ
    Am J Physiol; 1997 Apr; 272(4 Pt 1):L573-9. PubMed ID: 9142927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
    Barrett RJ; Droppleman DA
    Am J Physiol; 1993 Nov; 265(5 Pt 2):F651-9. PubMed ID: 8238545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of phosphatidylcholine-specific phospholipase C in thromboxane A₂ receptor-mediated extracellular Ca²⁺ influx in rat aorta.
    Suzuki K; Saito SY; Ishikawa T
    Eur J Pharmacol; 2012 Feb; 677(1-3):123-30. PubMed ID: 22200631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TxA2-induced pulmonary artery contraction requires extracellular calcium.
    Liu F; Wu JY; Beasley D; Orr JA
    Respir Physiol; 1997 Aug; 109(2):155-66. PubMed ID: 9299647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans.
    Saino A; Pomidossi G; Perondi R; Valentini R; Rimini A; Di Francesco L; Mancia G
    Circulation; 1997 Jul; 96(1):148-53. PubMed ID: 9236429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction.
    Wang YX; Ding YJ; Zhu YZ; Shi Y; Yao T; Zhu YC
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H348-59. PubMed ID: 16951045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.